share_log

苑东生物:奥卡西平口服混悬液获药品注册证书

JRJ Finance ·  Jul 5 06:18

苑东生物公告,全资子公司成都硕德药业有限公司近日收到国家药监局核准签发的奥卡西平口服混悬液药品注册证书。该药品适用于治疗原发性全面性强直-阵挛发作和部分性发作,适用于成年人和2岁以上儿童。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment